Precision Medicine

The Duke Med Alumni News Fall '22 Issue's cover story is "Researchers at Duke are Creating More Precise Approaches to Stopping Tumors."

Learn how the Precision Cancer Medicine Initiative is advancing research, extending lives, and breaking down barriers to access.

For most cancers, advances in genomics haven't changed cancer diagnosis and treatment very much. Sandeep Dave, MD, MS, envisions a way to change that.

For Health Professionals: This conference on the widespread effects of COVID-19 on precision medicine features Dr. Fauci, ASCO, FDA, faculty & industry leaders.

Yousuf Zafar, MD, MHS, FASCO, was honored to deliver the keynote for this year's ASCO Gastrointestinal Cancers Symposium.

For some patients, targeted therapy is their best shot. The Molecular Tumor Board at DCI is matching more and more patients to approved therapies and clinical trials.

DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.

Ginsburg’s areas of focus include the study of novel paradigms for developing and translating genomic information into medical practice.